Myocardial Injuries and Hemodynamic Stress Biomarkers: a Comparison Between Transvenous and Subcutaneous ICD Shock
| Registry | NCT03458065, acronym MYSTIC |
|---|---|
| Status | Unknown |
| Study type | Observational |
| Enrollment | 100 (Estimated) |
| Sponsor | Monaldi Hospital (Other) |
| Conditions | ICD Shock Myocardial Injuries |
| Interventions | ICD (Device) |
| Dates | start 2018-04-01 (estimated), primary completion 2018-09-01 (estimated), completion 2019-03-01 (estimated), first posted 2018-03-08, last updated 2018-03-08 |
| Locations | 1 site in Italy |
Related Papers Related Patents Related Grants Related Experts
All trials for ICD Shock Myocardial Injuries All trials of ICD
Implantable cardioverter defibrillator (ICD) shocks are associated with a subsequent increased risk of death, and an elevation of cardiac enzymes has been measured after defibrillation testing (DFT). The aim of our study was to investigate the association between S-ICD vs T-ICD shocks and acute cardiac damage in humans, as evaluated by means of sensitive and highly specific circulating biomarkers
| Arm | Type | Interventions | Description |
|---|---|---|---|
| S-ICD | Device: ICD | ||
| T-ICD | Device: ICD |
Sex: All, ages: 18 Years to any
Inclusion Criteria: patients who met the criteria for ICD implantation according to the current guidelines Exclusion Criteria: \-
| Facility | City | Country | Status |
|---|---|---|---|
| Monaldi Hospital | Naples | Italy |